Acute heart failure in a patient with metabolic syndrome and diabetes mellitus: clinical evidence for direct positive influence of antidiabetic therapy on left ventricular function.
Ritzel
Andreas
A
Department of Cardiology and Angiology, Elisabeth Hospital, Klara-Kopp-Weg 1, Essen 45138, Germany. a.ritzel@contilia.de
Bell
Michael
M
Jensen
Christoph
C
Sabin
Georg
G
D000208:Acute Disease; D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use; D048909:Diabetes Complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use; D016277:Ventricular Function, Left / Q000187:drug effects*
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; C072379:repaglinide